Skip to main content
. 2017 Sep 1;11(9):FF01–FF03. doi: 10.7860/JCDR/2017/29515.10534

[Table/Fig-1]:

Table showing the mean body weight increase of rats after intravenous administration of mesenchymal stromal cells in the 30-day safety study.

Groups (n=6) Mean body weight (gm) on day 0 Mean body weight (gm) on day 30
Normal control 169.6 ± 4.8 177.6 ± 5.9
Low dose BM-MSCs 155.3 ± 8.7 164.8 ± 9.3
High dose BM-MSCs 167.3 ±6.5 177.6 ± 7.0*

Values are expressed as mean±SEM. Tukey’s post hoc test indicated statistically significant difference in body weights of high dose BMMSCs group when compared to low dose BMMSCs group on day 30, (* p<0.05). n: Number of rats in each group. BMMSCs: Bone Marrow-derived Mesenchymal Stromal Cells.